Plasma Catecholamine Profile of Subarachnoid Hemorrhage Patients with Neurogenic Cardiomyopathy
Purpose: To investigate the connection between sympathetic function and neurogenic cardiomyopathy (NC), and to determine whether NC is mediated primarily by circulating adrenal epinephrine (EPI) or neuronally transmitted norepinephrine (NE), following subarachnoid hemorrhage (SAH). Methods: This is...
Gespeichert in:
Veröffentlicht in: | Cerebrovascular Diseases Extra 2015-05, Vol.5 (2), p.57-67 |
---|---|
Hauptverfasser: | , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 67 |
---|---|
container_issue | 2 |
container_start_page | 57 |
container_title | Cerebrovascular Diseases Extra |
container_volume | 5 |
creator | Moussouttas, Michael Mearns, Elizabeth Walters, Arthur DeCaro, Matthew |
description | Purpose: To investigate the connection between sympathetic function and neurogenic cardiomyopathy (NC), and to determine whether NC is mediated primarily by circulating adrenal epinephrine (EPI) or neuronally transmitted norepinephrine (NE), following subarachnoid hemorrhage (SAH). Methods: This is a prospective observational investigation of consecutive severe-grade SAH patients. All participants had transthoracic echocardiography and serological assays for catecholamine levels - dopamine (DA), NE and EPI - within 48 h of hemorrhage onset. Clinical and serological independent predictors of NC were determined using multivariate logistic regression analyses, and the accuracy of predictors was assessed by receiver operating characteristic (ROC) curves. Multivariate linear regression analyses were used to evaluate correlations among the catecholamines. Results: The investigation included a total of 94 subjects: the mean age was 55 years, 81% were female and 57% were Caucasian. NC was identified in approximately 10% (9/94) of cases. Univariate analyses revealed associations between NC and worse clinical severity (p = 0.019), plasma DA (p = 0.018) and NE levels (p = 0.024). Plasma NE correlated with DA levels (ρ = 0.206, p = 0.046) and EPI levels (ρ = 0.392, p < 0.001), but was predicted only by plasma EPI in bivariate [parameter estimate (PE) = 1.95, p < 0.001] and multivariate (PE = 1.89, p < 0.001) linear regression models. Multivariate logistic regression analyses consistently demonstrated the predictive value of clinical grade for NC (p < 0.05 for all analyses) except in models incorporating plasma NE, where NC was independently predicted by NE level (OR 1.25, 95% CI 1.01-1.55) over clinical grade (OR 4.19, 95% CI 0.874-20.1). ROC curves similarly revealed the greater accuracy of plasma NE [area under the curve (AUC) 0.727, 95% CI 0.56-0.90, p = 0.02] over clinical grade (AUC 0.704, 95% CI 0.55-0.86, p = 0.05) for identifying the presence or absence of NC. Conclusions: Following SAH, the development of NC is primarily related to elevated plasma NE levels. Findings implicate a predominantly neurogenic process mediated by neuronal NE (and not adrenal EPI), but cannot exclude synergy between the catecholamines. |
doi_str_mv | 10.1159/000431155 |
format | Article |
fullrecord | <record><control><sourceid>gale_karge</sourceid><recordid>TN_cdi_karger_primary_431155</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A636999829</galeid><doaj_id>oai_doaj_org_article_dde2d86e96a84c81a6ed6a830c87dd42</doaj_id><sourcerecordid>A636999829</sourcerecordid><originalsourceid>FETCH-LOGICAL-c583t-763db8ea480b7027b0e018e910d3c89ed7894c83d159fa58595faa496e2602b43</originalsourceid><addsrcrecordid>eNptks-L1TAQgIso7vLcg3eRghc9vDW_miYXYXk83YVFF9RzmCbTNmvbPNNWef-9WbuWXZAcMmS--ZhhkmUvKTmntNDvCSGCp6h4kp1SKcW2EIV8-iA-yc7G8TZhRBLKNX2enTBJGeGMnWbmpoOxh3wHE9o2dND7AfObGGrfYR7q_OtcQQTbDsG7_BL7EGMLTUJg8jhMY_7bT23-GecYGhy8TabofOiP4QBTe3yRPauhG_Hs_t5k3z_uv-0ut9dfPl3tLq63tlB82paSu0ohCEWqkrCyIkioQk2J41ZpdKXSwiru0sQ1FKrQRQ0gtEQmCasE32RXi9cFuDWH6HuIRxPAm78PITYG4uRth8Y5ZE5J1BJUclKQ6FLIiVWlc4Il14fFdZirHp1NY0boHkkfZwbfmib8MkKUitMiCd7eC2L4OeM4md6PFrsOBgzzaKjUjGkuCp7Q8wVtILXmhzoko03HYe9tGPBuD-ZCcqm1Vqlok71bCmwM4xixXvuixNx9CLN-iMS-fjjISv5bfwJeLcAPiA3GFVjr3_w3vdvvF8IcXM3_AJPOxbA</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1692293453</pqid></control><display><type>article</type><title>Plasma Catecholamine Profile of Subarachnoid Hemorrhage Patients with Neurogenic Cardiomyopathy</title><source>DOAJ Directory of Open Access Journals</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>PubMed Central</source><source>Karger Open Access</source><creator>Moussouttas, Michael ; Mearns, Elizabeth ; Walters, Arthur ; DeCaro, Matthew</creator><creatorcontrib>Moussouttas, Michael ; Mearns, Elizabeth ; Walters, Arthur ; DeCaro, Matthew</creatorcontrib><description>Purpose: To investigate the connection between sympathetic function and neurogenic cardiomyopathy (NC), and to determine whether NC is mediated primarily by circulating adrenal epinephrine (EPI) or neuronally transmitted norepinephrine (NE), following subarachnoid hemorrhage (SAH). Methods: This is a prospective observational investigation of consecutive severe-grade SAH patients. All participants had transthoracic echocardiography and serological assays for catecholamine levels - dopamine (DA), NE and EPI - within 48 h of hemorrhage onset. Clinical and serological independent predictors of NC were determined using multivariate logistic regression analyses, and the accuracy of predictors was assessed by receiver operating characteristic (ROC) curves. Multivariate linear regression analyses were used to evaluate correlations among the catecholamines. Results: The investigation included a total of 94 subjects: the mean age was 55 years, 81% were female and 57% were Caucasian. NC was identified in approximately 10% (9/94) of cases. Univariate analyses revealed associations between NC and worse clinical severity (p = 0.019), plasma DA (p = 0.018) and NE levels (p = 0.024). Plasma NE correlated with DA levels (ρ = 0.206, p = 0.046) and EPI levels (ρ = 0.392, p < 0.001), but was predicted only by plasma EPI in bivariate [parameter estimate (PE) = 1.95, p < 0.001] and multivariate (PE = 1.89, p < 0.001) linear regression models. Multivariate logistic regression analyses consistently demonstrated the predictive value of clinical grade for NC (p < 0.05 for all analyses) except in models incorporating plasma NE, where NC was independently predicted by NE level (OR 1.25, 95% CI 1.01-1.55) over clinical grade (OR 4.19, 95% CI 0.874-20.1). ROC curves similarly revealed the greater accuracy of plasma NE [area under the curve (AUC) 0.727, 95% CI 0.56-0.90, p = 0.02] over clinical grade (AUC 0.704, 95% CI 0.55-0.86, p = 0.05) for identifying the presence or absence of NC. Conclusions: Following SAH, the development of NC is primarily related to elevated plasma NE levels. Findings implicate a predominantly neurogenic process mediated by neuronal NE (and not adrenal EPI), but cannot exclude synergy between the catecholamines.</description><identifier>ISSN: 1664-5456</identifier><identifier>EISSN: 1664-5456</identifier><identifier>DOI: 10.1159/000431155</identifier><identifier>PMID: 26120322</identifier><language>eng</language><publisher>Basel, Switzerland: S. Karger AG</publisher><subject>Cardiomyopathy ; Catecholamines ; Complications and side effects ; Development and progression ; Health aspects ; Heart diseases ; Neurogenic cardiomyopathy ; Norepinephrine ; Original Paper ; Physiological aspects ; Risk factors ; Subarachnoid hemorrhage ; Sympathetic function</subject><ispartof>Cerebrovascular Diseases Extra, 2015-05, Vol.5 (2), p.57-67</ispartof><rights>2015 S. Karger AG, Basel</rights><rights>COPYRIGHT 2015 S. Karger AG</rights><rights>Copyright © 2015 by S. Karger AG, Basel 2015</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c583t-763db8ea480b7027b0e018e910d3c89ed7894c83d159fa58595faa496e2602b43</citedby><cites>FETCH-LOGICAL-c583t-763db8ea480b7027b0e018e910d3c89ed7894c83d159fa58595faa496e2602b43</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC4478315/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC4478315/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,723,776,780,860,881,2095,27614,27903,27904,53769,53771</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/26120322$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Moussouttas, Michael</creatorcontrib><creatorcontrib>Mearns, Elizabeth</creatorcontrib><creatorcontrib>Walters, Arthur</creatorcontrib><creatorcontrib>DeCaro, Matthew</creatorcontrib><title>Plasma Catecholamine Profile of Subarachnoid Hemorrhage Patients with Neurogenic Cardiomyopathy</title><title>Cerebrovascular Diseases Extra</title><addtitle>Cerebrovasc Dis Extra</addtitle><description>Purpose: To investigate the connection between sympathetic function and neurogenic cardiomyopathy (NC), and to determine whether NC is mediated primarily by circulating adrenal epinephrine (EPI) or neuronally transmitted norepinephrine (NE), following subarachnoid hemorrhage (SAH). Methods: This is a prospective observational investigation of consecutive severe-grade SAH patients. All participants had transthoracic echocardiography and serological assays for catecholamine levels - dopamine (DA), NE and EPI - within 48 h of hemorrhage onset. Clinical and serological independent predictors of NC were determined using multivariate logistic regression analyses, and the accuracy of predictors was assessed by receiver operating characteristic (ROC) curves. Multivariate linear regression analyses were used to evaluate correlations among the catecholamines. Results: The investigation included a total of 94 subjects: the mean age was 55 years, 81% were female and 57% were Caucasian. NC was identified in approximately 10% (9/94) of cases. Univariate analyses revealed associations between NC and worse clinical severity (p = 0.019), plasma DA (p = 0.018) and NE levels (p = 0.024). Plasma NE correlated with DA levels (ρ = 0.206, p = 0.046) and EPI levels (ρ = 0.392, p < 0.001), but was predicted only by plasma EPI in bivariate [parameter estimate (PE) = 1.95, p < 0.001] and multivariate (PE = 1.89, p < 0.001) linear regression models. Multivariate logistic regression analyses consistently demonstrated the predictive value of clinical grade for NC (p < 0.05 for all analyses) except in models incorporating plasma NE, where NC was independently predicted by NE level (OR 1.25, 95% CI 1.01-1.55) over clinical grade (OR 4.19, 95% CI 0.874-20.1). ROC curves similarly revealed the greater accuracy of plasma NE [area under the curve (AUC) 0.727, 95% CI 0.56-0.90, p = 0.02] over clinical grade (AUC 0.704, 95% CI 0.55-0.86, p = 0.05) for identifying the presence or absence of NC. Conclusions: Following SAH, the development of NC is primarily related to elevated plasma NE levels. Findings implicate a predominantly neurogenic process mediated by neuronal NE (and not adrenal EPI), but cannot exclude synergy between the catecholamines.</description><subject>Cardiomyopathy</subject><subject>Catecholamines</subject><subject>Complications and side effects</subject><subject>Development and progression</subject><subject>Health aspects</subject><subject>Heart diseases</subject><subject>Neurogenic cardiomyopathy</subject><subject>Norepinephrine</subject><subject>Original Paper</subject><subject>Physiological aspects</subject><subject>Risk factors</subject><subject>Subarachnoid hemorrhage</subject><subject>Sympathetic function</subject><issn>1664-5456</issn><issn>1664-5456</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2015</creationdate><recordtype>article</recordtype><sourceid>M--</sourceid><sourceid>DOA</sourceid><recordid>eNptks-L1TAQgIso7vLcg3eRghc9vDW_miYXYXk83YVFF9RzmCbTNmvbPNNWef-9WbuWXZAcMmS--ZhhkmUvKTmntNDvCSGCp6h4kp1SKcW2EIV8-iA-yc7G8TZhRBLKNX2enTBJGeGMnWbmpoOxh3wHE9o2dND7AfObGGrfYR7q_OtcQQTbDsG7_BL7EGMLTUJg8jhMY_7bT23-GecYGhy8TabofOiP4QBTe3yRPauhG_Hs_t5k3z_uv-0ut9dfPl3tLq63tlB82paSu0ohCEWqkrCyIkioQk2J41ZpdKXSwiru0sQ1FKrQRQ0gtEQmCasE32RXi9cFuDWH6HuIRxPAm78PITYG4uRth8Y5ZE5J1BJUclKQ6FLIiVWlc4Il14fFdZirHp1NY0boHkkfZwbfmib8MkKUitMiCd7eC2L4OeM4md6PFrsOBgzzaKjUjGkuCp7Q8wVtILXmhzoko03HYe9tGPBuD-ZCcqm1Vqlok71bCmwM4xixXvuixNx9CLN-iMS-fjjISv5bfwJeLcAPiA3GFVjr3_w3vdvvF8IcXM3_AJPOxbA</recordid><startdate>201505</startdate><enddate>201505</enddate><creator>Moussouttas, Michael</creator><creator>Mearns, Elizabeth</creator><creator>Walters, Arthur</creator><creator>DeCaro, Matthew</creator><general>S. Karger AG</general><general>Karger Publishers</general><scope>M--</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>IAO</scope><scope>7X8</scope><scope>5PM</scope><scope>DOA</scope></search><sort><creationdate>201505</creationdate><title>Plasma Catecholamine Profile of Subarachnoid Hemorrhage Patients with Neurogenic Cardiomyopathy</title><author>Moussouttas, Michael ; Mearns, Elizabeth ; Walters, Arthur ; DeCaro, Matthew</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c583t-763db8ea480b7027b0e018e910d3c89ed7894c83d159fa58595faa496e2602b43</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2015</creationdate><topic>Cardiomyopathy</topic><topic>Catecholamines</topic><topic>Complications and side effects</topic><topic>Development and progression</topic><topic>Health aspects</topic><topic>Heart diseases</topic><topic>Neurogenic cardiomyopathy</topic><topic>Norepinephrine</topic><topic>Original Paper</topic><topic>Physiological aspects</topic><topic>Risk factors</topic><topic>Subarachnoid hemorrhage</topic><topic>Sympathetic function</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Moussouttas, Michael</creatorcontrib><creatorcontrib>Mearns, Elizabeth</creatorcontrib><creatorcontrib>Walters, Arthur</creatorcontrib><creatorcontrib>DeCaro, Matthew</creatorcontrib><collection>Karger Open Access</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Gale Academic OneFile</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><collection>DOAJ Directory of Open Access Journals</collection><jtitle>Cerebrovascular Diseases Extra</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Moussouttas, Michael</au><au>Mearns, Elizabeth</au><au>Walters, Arthur</au><au>DeCaro, Matthew</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Plasma Catecholamine Profile of Subarachnoid Hemorrhage Patients with Neurogenic Cardiomyopathy</atitle><jtitle>Cerebrovascular Diseases Extra</jtitle><addtitle>Cerebrovasc Dis Extra</addtitle><date>2015-05</date><risdate>2015</risdate><volume>5</volume><issue>2</issue><spage>57</spage><epage>67</epage><pages>57-67</pages><issn>1664-5456</issn><eissn>1664-5456</eissn><abstract>Purpose: To investigate the connection between sympathetic function and neurogenic cardiomyopathy (NC), and to determine whether NC is mediated primarily by circulating adrenal epinephrine (EPI) or neuronally transmitted norepinephrine (NE), following subarachnoid hemorrhage (SAH). Methods: This is a prospective observational investigation of consecutive severe-grade SAH patients. All participants had transthoracic echocardiography and serological assays for catecholamine levels - dopamine (DA), NE and EPI - within 48 h of hemorrhage onset. Clinical and serological independent predictors of NC were determined using multivariate logistic regression analyses, and the accuracy of predictors was assessed by receiver operating characteristic (ROC) curves. Multivariate linear regression analyses were used to evaluate correlations among the catecholamines. Results: The investigation included a total of 94 subjects: the mean age was 55 years, 81% were female and 57% were Caucasian. NC was identified in approximately 10% (9/94) of cases. Univariate analyses revealed associations between NC and worse clinical severity (p = 0.019), plasma DA (p = 0.018) and NE levels (p = 0.024). Plasma NE correlated with DA levels (ρ = 0.206, p = 0.046) and EPI levels (ρ = 0.392, p < 0.001), but was predicted only by plasma EPI in bivariate [parameter estimate (PE) = 1.95, p < 0.001] and multivariate (PE = 1.89, p < 0.001) linear regression models. Multivariate logistic regression analyses consistently demonstrated the predictive value of clinical grade for NC (p < 0.05 for all analyses) except in models incorporating plasma NE, where NC was independently predicted by NE level (OR 1.25, 95% CI 1.01-1.55) over clinical grade (OR 4.19, 95% CI 0.874-20.1). ROC curves similarly revealed the greater accuracy of plasma NE [area under the curve (AUC) 0.727, 95% CI 0.56-0.90, p = 0.02] over clinical grade (AUC 0.704, 95% CI 0.55-0.86, p = 0.05) for identifying the presence or absence of NC. Conclusions: Following SAH, the development of NC is primarily related to elevated plasma NE levels. Findings implicate a predominantly neurogenic process mediated by neuronal NE (and not adrenal EPI), but cannot exclude synergy between the catecholamines.</abstract><cop>Basel, Switzerland</cop><pub>S. Karger AG</pub><pmid>26120322</pmid><doi>10.1159/000431155</doi><tpages>11</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1664-5456 |
ispartof | Cerebrovascular Diseases Extra, 2015-05, Vol.5 (2), p.57-67 |
issn | 1664-5456 1664-5456 |
language | eng |
recordid | cdi_karger_primary_431155 |
source | DOAJ Directory of Open Access Journals; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; PubMed Central; Karger Open Access |
subjects | Cardiomyopathy Catecholamines Complications and side effects Development and progression Health aspects Heart diseases Neurogenic cardiomyopathy Norepinephrine Original Paper Physiological aspects Risk factors Subarachnoid hemorrhage Sympathetic function |
title | Plasma Catecholamine Profile of Subarachnoid Hemorrhage Patients with Neurogenic Cardiomyopathy |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-27T05%3A56%3A45IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_karge&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Plasma%20Catecholamine%20Profile%20of%20Subarachnoid%20Hemorrhage%20Patients%20with%20Neurogenic%20Cardiomyopathy&rft.jtitle=Cerebrovascular%20Diseases%20Extra&rft.au=Moussouttas,%20Michael&rft.date=2015-05&rft.volume=5&rft.issue=2&rft.spage=57&rft.epage=67&rft.pages=57-67&rft.issn=1664-5456&rft.eissn=1664-5456&rft_id=info:doi/10.1159/000431155&rft_dat=%3Cgale_karge%3EA636999829%3C/gale_karge%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1692293453&rft_id=info:pmid/26120322&rft_galeid=A636999829&rft_doaj_id=oai_doaj_org_article_dde2d86e96a84c81a6ed6a830c87dd42&rfr_iscdi=true |